-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Encompass Health, Raises Price Target to $151

Benzinga·10/29/2026 15:00:54
Listen to the news
Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $144 to $151.